Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunological Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01593410
What this trial is testing

Study of Lenalidomide and Low-Dose Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 194
Not applicableWithdrawnNCT02412813
What this trial is testing

LEGION™ Revision Metal Hypersensitivity Study

Who this might be right for
Total Knee Replacement Revision
Smith & Nephew, Inc.
Large-scale testing (Phase 3)Study completedNCT04806113
What this trial is testing

COVID-19 Vaccine in Immunosuppressed Adults With Autoimmune Diseases

Who this might be right for
Covid19Rheumatic DiseasesRheumatoid Arthritis+1 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 220
Not applicableUnknownNCT03953482
What this trial is testing

Evaluation of Medical Care and Patient's Knowledge About the Behavior to Take on Secondary Prevention of Anaphylaxis

Who this might be right for
Anaphylaxis
Fondation Hôpital Saint-Joseph 66
Not applicableUnknownNCT04469582
What this trial is testing

The Association of Bullous Pemphigoid With Dipeptidyl-peptidase 4 Inhibitors

Who this might be right for
Bullous Pemphigoid
University of Athens 113
Not applicableNot Yet RecruitingNCT07645313
What this trial is testing

Accuracy and Safety of Anytime 5Pro and Anytime 4Pro CGM Systems in Adults With Diabetes

Who this might be right for
Diabetes Mellitus, Type 1 | Diabetes Mellitus, Type 2
Yuwell Group 70
Testing effectiveness (Phase 2)Ended earlyNCT04676360
What this trial is testing

Belantamab Mafodotin In Plasmablastic Lymphoma & ALK+ Large B-Cell Lymphoma

Who this might be right for
Relapsed Plasmablastic LymphomaRefractory Plasmablastic LymphomaAnaplastic Lymphoma Kinase Positive Large B-Cell Lymphoma
Jacob Soumerai, MD 10
Large-scale testing (Phase 3)Study completedNCT00122382
What this trial is testing

Remission and Joint Damage Progression in Early Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 1,052
Not applicableStudy completedNCT02671682
What this trial is testing

Immunoadsorption vs. Plasmapheresis in the Escalation Therapy of Relapse in Multiple Sclerosis

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
Albert Christian Ludolph, Prof. 61
Testing effectiveness (Phase 2)Study completedNCT00038623
What this trial is testing

Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma

Who this might be right for
Lymphoma, Mantle-Cell
M.D. Anderson Cancer Center 35
Testing effectiveness (Phase 2)UnknownNCT00202423
What this trial is testing

Use of Cannabinoids in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
S. Andrea Hospital 20
Post-approval studies (Phase 4)Study completedNCT04157738
What this trial is testing

Rapid-Acting Mealtime Insulin in Children and Adolescents With Newly Diagnosed Type 1 Diabetes Mellitus

Who this might be right for
Diabetes MellitusType 1 Diabetes
Emory University 24
Not applicableStudy completedNCT03324438
What this trial is testing

Home Telemedicine to Optimize Health Outcomes in High-Risk Youth With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
University of Colorado, Denver 108
Testing effectiveness (Phase 2)Active Not RecruitingNCT04515238
What this trial is testing

Sequential Regimen of Bendamustine Followed by Obinutuzumab (GA101), Zanubrutinib (BGB-3111) and Venetoclax (ABT-199) in Patients With Relapsed/Refractory CLL

Who this might be right for
Chronic Lymphoid Leukemia
German CLL Study Group 42
Testing effectiveness (Phase 2)Ended earlyNCT04524858
What this trial is testing

Study of ATI-450 in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS)

Who this might be right for
Cryopyrin-Associated Periodic Syndrome
Aclaris Therapeutics, Inc. 1
Testing effectiveness (Phase 2)Study completedNCT02443155
What this trial is testing

A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 308
Not applicableStudy completedNCT07158385
What this trial is testing

Effect of High Fat High Protein Meal in Type 1 Diabetes

Who this might be right for
Type 1 Diabetes MellitusAdolescent
Cumhuriyet University 11
Early research (Phase 1)Study completedNCT02945215
What this trial is testing

Assess the Pharmacokinetics and Safety of Recombinant Human Murine Chimeric Anti CD20 Monoclonal Antibody Injection (IBI301) Compared to Rituximab Injection in CD20 Positive B Cell Lymphoma Patients

Who this might be right for
B-Cell Lymphoma
Innovent Biologics (Suzhou) Co. Ltd. 181
Not applicableUnknownNCT02570776
What this trial is testing

UBT as a Diagnostic Tool for HP Prevalance

Who this might be right for
Dyspepsia
National Institute of Liver & GI Diseases, Pakistan 200
Testing effectiveness (Phase 2)Looking for participantsNCT07471789
What this trial is testing

Safety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL).

Who this might be right for
Acute Myeloblastic LeukaemiaLeukemia, T-Cell
Gyala Therapeutics 33
Next Page